This section of the website contains information that should be considered accurate as of the date presented. You acknowledge that this information may change over time and you should not assume that the information is accurate at a later date. Quest Diagnostics is not obligated to update the information contained in this section of the website.
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it will report second quarter 2019 results on Tuesday, July 23, 2019,...
SECAUCUS, NJ, July 9, 2019 -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today launched a new Lyme Disease test offering that individuals can...
SECAUCUS, N.J. and EDEN PRAIRIE, Minn. (July 9, 2019) – As recently reported in numerous media outlets, on May 14, 2019, Retrieval-Masters Creditors Bureau, Inc./American Medical Collection...
Individuals with prediabetes who participate in an employer-sponsored digital diabetes-prevention counseling program may reduce their risk of developing type 2 diabetes (T2D) for up to eight...
American Medical Collection Agency (AMCA), a collection agency, has disclosed that an unauthorized user had access to AMCA’s system between August 1, 2018, and March 30, 2019.
American Medical Collection Agency (AMCA), a billing collections service provider, has informed Quest Diagnostics that an unauthorized user had access to AMCA’s system containing personal...
Quest Diagnostics (NYSE: DGX), a leading provider of diagnostic information services, today announced it is participating as a designated laboratory in the NCI-Molecular Analysis for Therapy...
Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that its Board of Directors declared a quarterly cash dividend of $0.53 per share,...
Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it is scheduled to speak at the UBS Global Healthcare Conference in New...
Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced today financial results for the first quarter ended March 31, 2019. "We're...